NanoBioFAB Secures $1.1M DHA SBIR Phase II contract for Revolutionary AI-Driven Nanosensor Technology in Pathogen Detection and Wound Infection Prediction Device
Frederick, MD (PRWEB) July 13, 2023 -- NanoBioFAB, an innovative medical device company with advanced AI-driven nanosensor technology, is pleased to announce...
Read disclosure →